The EML4-ALK oncogene is already well described [176,177], but ALK can also form rearrangements with CMTR1. It is yet to be confirmed if the CMTR1-ALK fusion gene is also oncogenic and if it has a role in cancer drug resistance [178]. This evidence concerns the gene ALK and cancer.